3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic MigraineEpisodic MigraineRecruitingPhase 32026-10-06NCT05711394
A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney DiseaseChronic Disease, Disease Attributes, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Urogenital Diseases, anemia, chronic renal failure syndrome, hematologic disorder, kidney disorder, kidney failure, urinary system disorderRecruitingPhase 32026-09-22NCT05970172
Long-term Extension Study to Assess Adverse Events of Oral Atogepant Tablets in Pediatric Participants (6 to 17 Years of Age) With MigraineMigraine ProphylaxisEnrolling by invitationPhase 32025-08-11NCT05707949